Drug Topics June 20, 2024
Research presented at ASHP 2024 found that concerns around the safety of COVID-19 vaccines and the credibility of information from public health authorities were the biggest drivers of vaccine hesitancy during the COVID-19 pandemic.
Relationships between patients and their providers need to be improved before the next global medical crisis in order for vaccine hesitancy to be less of an issue than it was during the COVID-19 pandemic, according to research presented at the ASHP Pharmacy Futures 2024 conference, held June 8 to 12 in Portland, Oregon.1
Although vaccine hesitancy, which refers to a delay or refusal in the acceptance of vaccines, has long been a public health issue, it was significantly exacerbated during the COVID-19 pandemic. According to research...